ARTICLE SUMMARY:
In the past decade, flow diverters have improved the standard of endovascular care for cerebral aneurysms, but using existing devices to treat aneurysms at bifurcations has been less successful. While many companies are innovating around this problem, early-stage NeuroMedica believes its patented concept enables a simpler solution.
Like many medical start-ups, NeuroMedica Inc., which is developing a new implant for the treatment of cerebral aneurysms, was founded by a clinician who thought there had to be a better way.
